SG11201501657XA - Treatment of post-traumatic stress disorder with isolated mycobacterium - Google Patents

Treatment of post-traumatic stress disorder with isolated mycobacterium

Info

Publication number: SG11201501657XA
Authority: SG; Singapore
Prior art keywords: post; treatment; stress disorder; traumatic stress; isolated mycobacterium
Prior art date: 2012-09-20

Application number

SG11201501657XA

Inventor

Charles Akle

John Grange

Original Assignee

Immodulon Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-20

Filing date

2013-09-17

Publication date

2015-04-29

2013-09-17 Application filed by Immodulon Therapeutics Ltd filed Critical Immodulon Therapeutics Ltd

2015-04-29 Publication of SG11201501657XA publication Critical patent/SG11201501657XA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Biochemistry (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

SG11201501657XA 2012-09-20 2013-09-17 Treatment of post-traumatic stress disorder with isolated mycobacterium SG11201501657XA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB1216800.1A GB201216800D0 (en)	2012-09-20	2012-09-20	Novel use
PCT/GB2013/052430 WO2014045023A1 (en)	2012-09-20	2013-09-17	Treatment of post-traumatic stress disorder with isolated mycobacterium

Publications (1)

Publication Number	Publication Date
SG11201501657XA true SG11201501657XA (en)	2015-04-29

Family

ID=47190336

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG11201501657XA SG11201501657XA (en)	2012-09-20	2013-09-17	Treatment of post-traumatic stress disorder with isolated mycobacterium
SG10201707115WA SG10201707115WA (en)	2012-09-20	2013-09-17	Treatment Of Post-Traumatic Stress Disorder With Isolated Mycobacterium

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG10201707115WA SG10201707115WA (en)	2012-09-20	2013-09-17	Treatment Of Post-Traumatic Stress Disorder With Isolated Mycobacterium

Country Status (16)

Country	Link
US (1)	US10071124B2 (en)
EP (1)	EP2897636B1 (en)
JP (1)	JP6086985B2 (en)
CN (1)	CN104703621B (en)
AU (1)	AU2013319981B2 (en)
CA (1)	CA2884295C (en)
DK (1)	DK2897636T3 (en)
ES (1)	ES2704653T3 (en)
GB (1)	GB201216800D0 (en)
IL (1)	IL237460B (en)
MX (1)	MX2015003048A (en)
NZ (1)	NZ705539A (en)
RU (1)	RU2670751C9 (en)
SG (2)	SG11201501657XA (en)
SI (1)	SI2897636T1 (en)
WO (1)	WO2014045023A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG190612A1 (en)	2009-06-09	2013-06-28	Cimas Ltd	Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
US11110070B2 (en)	2015-11-17	2021-09-07	The Trustees Of Columbia University In The City Of New York	Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
BR112020001074A2 (en) *	2017-07-19	2020-07-14	Hoffman Technologies, Inc.	composition
US10426836B2 (en)	2017-07-19	2019-10-01	Hoffman Technologies, Inc.	Compositions and methods for treating stress-related disorders
US11077179B2 (en)	2017-08-10	2021-08-03	Epicgenetics, Inc.	Method for treating fibromyalgia and chronic fatigue syndrome
WO2019094596A1 (en)	2017-11-09	2019-05-16	The Trustees Of Columbia University In The City Of New York	Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
US11491120B2 (en)	2017-11-09	2022-11-08	The Trustees Of Columbia University In The City Of New York	Pharmacological prophylactics against stress-induced affective disorders in females
WO2019246282A1 (en)	2018-06-19	2019-12-26	The Regents Of The University Of Colorado	Protection from stress, anxiety, neuroinflammation and cognitive dysfunction
US11471496B2 (en) *	2019-02-28	2022-10-18	Rowan University	Compositions and methods for treating or ameliorating cocaine addiction
AU2020276605A1 (en)	2019-05-14	2022-01-20	Tyme, Inc.	Compositions and methods for treating cancer
WO2020232246A1 (en) *	2019-05-15	2020-11-19	The Trustees Of Columbia University In The City Of New York	Compositions and methods against stress-induced affective disorders and their associated symptoms
US10905698B1 (en)	2020-05-14	2021-02-02	Tyme, Inc.	Methods of treating SARS-COV-2 infections
WO2025059196A1 (en) *	2023-09-13	2025-03-20	The Regents Of The University Of Colorado A Body Corporate	Soil-derived mycobacterium promotes immunoregulation and stress resilience
CN117860892B (en) *	2023-12-26	2024-08-06	武汉大学中南医院	IL-16 positive neurons in the modulation of fear-resolved memory

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0010496D0 (en)	2000-04-28	2000-06-14	Stanford Rook Ltd	Treatment of conditions of the central nervous system
GB0526033D0 (en) *	2005-12-21	2006-02-01	Bioeos Ltd	Method
UA59766U (en) *	2010-11-30	2011-05-25	Анна Александровна Григорович	Method for medical rehabilitation of adult patients with post-traumatic stress

2012
- 2012-09-20 GB GBGB1216800.1A patent/GB201216800D0/en not_active Ceased
2013
- 2013-09-17 SG SG11201501657XA patent/SG11201501657XA/en unknown
- 2013-09-17 NZ NZ705539A patent/NZ705539A/en not_active IP Right Cessation
- 2013-09-17 MX MX2015003048A patent/MX2015003048A/en active IP Right Grant
- 2013-09-17 EP EP13770960.6A patent/EP2897636B1/en not_active Not-in-force
- 2013-09-17 AU AU2013319981A patent/AU2013319981B2/en not_active Ceased
- 2013-09-17 ES ES13770960T patent/ES2704653T3/en active Active
- 2013-09-17 SI SI201331316T patent/SI2897636T1/en unknown
- 2013-09-17 JP JP2015532500A patent/JP6086985B2/en not_active Expired - Fee Related
- 2013-09-17 WO PCT/GB2013/052430 patent/WO2014045023A1/en not_active Ceased
- 2013-09-17 RU RU2015114256A patent/RU2670751C9/en active
- 2013-09-17 CA CA2884295A patent/CA2884295C/en not_active Expired - Fee Related
- 2013-09-17 DK DK13770960.6T patent/DK2897636T3/en active
- 2013-09-17 SG SG10201707115WA patent/SG10201707115WA/en unknown
- 2013-09-17 CN CN201380048853.6A patent/CN104703621B/en not_active Expired - Fee Related
- 2013-09-17 US US14/429,697 patent/US10071124B2/en active Active
2015
- 2015-02-26 IL IL237460A patent/IL237460B/en active IP Right Grant

Also Published As

Publication number	Publication date
CA2884295C (en)	2021-08-24
US10071124B2 (en)	2018-09-11
NZ705539A (en)	2018-09-28
IL237460A0 (en)	2015-04-30
US20150246080A1 (en)	2015-09-03
RU2015114256A (en)	2016-11-10
SI2897636T1 (en)	2019-03-29
AU2013319981A1 (en)	2015-03-19
RU2670751C2 (en)	2018-10-25
EP2897636B1 (en)	2018-11-07
SG10201707115WA (en)	2017-09-28
CN104703621A (en)	2015-06-10
WO2014045023A1 (en)	2014-03-27
MX2015003048A (en)	2015-11-16
RU2670751C9 (en)	2018-12-13
IL237460B (en)	2020-07-30
JP2015532921A (en)	2015-11-16
DK2897636T3 (en)	2019-01-28
CA2884295A1 (en)	2014-03-27
AU2013319981B2 (en)	2016-12-22
EP2897636A1 (en)	2015-07-29
JP6086985B2 (en)	2017-03-01
ES2704653T3 (en)	2019-03-19
CN104703621B (en)	2018-12-07
GB201216800D0 (en)	2012-11-07

Publication	Publication Date	Title
IL237460A0 (en)	2015-04-30	Treatment of post-traumatic stress disorder with isolated mycobacterium
ZA201502603B (en)	2018-11-28	Enhancement of the immune response
SG11201405057YA (en)	2014-09-26	Treatment of biomass
ZA201500152B (en)	2020-05-27	Methods of treating arthritis
GB201221329D0 (en)	2013-01-09	Dermatitis treatment
GB201506561D0 (en)	2015-06-03	Treatment of amblyopia
ZA201406082B (en)	2019-01-30	Use of ccr3-inhibitors
EP2867239A4 (en)	2015-12-23	Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
EP2827902A4 (en)	2016-01-20	Treatment of multiple sclerosis with anti-cd19 antibody
GB201309274D0 (en)	2013-07-10	Treatment Of Fuel
IL238174A0 (en)	2015-05-31	Combination therapy with volasertib
ZA201408058B (en)	2016-03-30	Compositions and methods for the treatment of epilepsy
EP2822594A4 (en)	2016-02-17	Methods of treatment with angiopoietin-2 antibodies
GB201213778D0 (en)	2012-09-12	Process and dressng
GB201207907D0 (en)	2012-06-20	Treatment of depression
GB201221118D0 (en)	2013-01-09	Methods of treatment
GB201216748D0 (en)	2012-10-31	Methods of treatment
GB201216740D0 (en)	2012-10-31	Methods of treatment
GB201206324D0 (en)	2012-05-23	Methods of treatment
GB201206325D0 (en)	2012-05-23	Methods of treatment
GB201206326D0 (en)	2012-05-23	Methods of treatment
GB201206330D0 (en)	2012-05-23	Methods of treatment
GB201208048D0 (en)	2012-06-20	Treatment of digestive disorder
TWM433525U (en)	2012-07-11	Structure of calorifier
IL233740A0 (en)	2014-09-30	Treatment of liver conditions